65,437 trials
Aspergillosis
Primary: Average of the Z-scores of the Time-Weighted Averages (TWA) of Fungal Biomarkers Galactomannan (GM) and (1,3)-β-D-glucan (βDG) Over the First Two Weeks of Treatment for…
HIV
Primary: Maximum Observed Plasma Concentration (Cmax) and Trough Observed Plasma Concentration (Ctrough) for Atazanavir and Ritonavir — 3512; 4131; 3322; 496 ng/mL
Tuberous Sclerosis Complex (TSC) · Lymphangioleiomyomatosis (LAM)
Primary: Angiomyolipoma Response Rate as Per Central Radiology Review — 41.8; 0; 58.0 Percentage of Participants — p=<0.0001
Contraception
Primary: The Change in Average of the 3 Highest Visual Analog Scale (VAS) Values of the Hormone Withdrawal-associated Symptoms Pelvic Pain or Headache During Cycle Days 22 to 28…
Extrahepatic Bile Duct Cancer · Gallbladder Cancer
Primary: Response — 7; 6; 12; 15 participants
Lupus Erythematosus, Systemic
Primary: Percentage Change From Baseline in Safety of Estrogens in Lupus Erythematosus National Assessment SLE Disease Activity Index (SELENA SLEDAI) Score at Week 24. — -17.2…
Arthroplasty, Replacement · Thromboembolism
Primary: Percentage of Patients With Major Bleeding Events (MBE) During Treatment Period — 0.72 Percentage of participants
Paroxysmal Atrial Fibrillation
Primary: Acute Procedural Success (APS) — 160 participants
Healthy
Primary: Time to Reach Maximum Serum Drug Concentration (Tmax) Following a Single Dose of Belimumab Given as Intravenous Infusion (IV) or Subcutaneous Injection (SC) — 0.09; 3.9…
Carcinoma of the Appendix · Colorectal Cancer
Primary: Time to Progression — 0.775 years
Non-Hodgkin's Lymphoma (NHL)
Primary: Percentage of Participants With a Best Overall Response of Complete Response (CR) or Partial Response (PR), as Determined by the International Working Group (IWG)…
Liposarcoma · Leiomyosarcoma · Fibrosarcoma
Primary: Number of Participants With Overall Response (OR) — 1 participants
Face-lift · Facial Rhytidectomy
Primary: Total Volume of Drainage on Each Side of the Face — 20.0; 8.0 mL — p=<0.0001
Type 2 Diabetes Mellitus
Primary: Change in Haemoglobin A1c (HbA1c) — 0.0; -0.3; 0.1; 0.2 Percentage
Facial Rhytidectomy (Face-lift)
Primary: Visual Comparison of Ecchymosis at Postoperative Day 3 — 5; 12; 11; 0 participants — p=0.143